Search Browse Earnings

Clene Inc. — SlamSEC

Clene Inc.

Nasdaq:CLNN

Pharmaceutical Preparations·SALT LAKE CITY, UT

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$654,000

+38.3% YoY

FY 2024

Adj. EBITDA

-$38.8M

-5938.1% margin

FY 2024

Net Income

-$49.5M

-7569.4% margin

FY 2024

EPS (Diluted)

-$9.43

FY 2024

Stock Price

$6.27

+12.4%

2026-03-13

52W Range

$2.28 – $13.50

P/E Ratio

-0.7x

Market Cap

$64.8M

Cash

$28.8M

FY 2024

Total Debt

$16.5M

FY 2024

Net Cash

$12.3M

FY 2024

Enterprise Value

$52.5M

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

-1.4x

Employees

—